Helena Xandri I Monje
About Helena Xandri I Monje
Helena Xandri I Monje is a scientist with a background in biochemistry and biotechnology. She has worked at various research institutions, including Adaptimmune and the Vall d’Hebron Institute of Research, and holds a Master's degree in Pharmaceutical Industry and Biotechnological Research.
Current Role at Adaptimmune
Helena Xandri I Monje has been employed as a Scientist at Adaptimmune since 2019. In this role, she contributes to the company's research and development efforts in the field of immunotherapy. Adaptimmune focuses on innovative treatments for cancer, utilizing T-cell therapy to target specific cancer cells. Helena's work is integral to advancing the company's mission and enhancing therapeutic options for patients.
Previous Experience in Research
Prior to her current position, Helena worked as a Research Technician at the University of Warwick from 2016 to 2019. During her three years there, she engaged in various research projects, contributing to the academic community in Coventry, United Kingdom. Additionally, she served as a Research Assistant at the Vall d’Hebron Institute of Research (VHIR) in Barcelona from 2014 to 2015, where she was involved in nanomedicine research.
Educational Background
Helena completed her Master's degree in Pharmaceutical Industry and Biotechnological Research at Universitat Pompeu Fabra from 2013 to 2014. She also holds a degree in Biochemistry from Universitat Autònoma de Barcelona, which she earned from 2009 to 2013. Her education has provided her with a solid foundation in biotechnology and pharmaceutical sciences.
Internship Experience
Helena has completed multiple internships that contributed to her professional development. She interned at the Parc de Recerca UAB - Institut de Biotecnologia i Biomedicina in 2011 for one month and again in 2012 for three months. These experiences allowed her to gain practical skills and insights into biotechnological research.
Language Proficiency
Helena studied at the British Council, where she achieved a score of 7.5 on the International English Language Testing System (IELTS). This certification demonstrates her proficiency in English, which is essential for her work in international research environments.